Vein Visualization Leader Sponsors Symposium at the American Organization for Nursing Leadership (AONL)
Improving the Nursing Environment and Patient Outcomes Key Focus of Discussion
MEDFORD, N.Y.–(BUSINESS WIRE)–AccuVein Inc., the global leader in Near Infrared (NIR) vein visualization, announced today that it is hosting a Sunrise Session Symposium, from 7-8 a.m., on Wednesday, April 13, 2022, at AONL in the San Antonio TX, Henry B. Gonzalez Convention Center.
The symposium is entitled, “Recover Nursing Time and Improve Patient Care with NIR Visualization.” Attendees will learn how to reduce workload stress, recover nursing time, and improve patient care by adding NIR vein visualization into their peripheral IV (PIV) site assessment and clinical protocol. The session will be led by Gregory J. Schears, MD and Thomas Hopkins, MD, MBA, CPE, who will collectively summarize evidence clarifying the value of NIR and review practice tips to improve patient satisfaction and enhance provider resilience for use with both adult and pediatric patients.
AONL attendees will also be able to visit AccuVein’s booth (#1042), on Monday, April 11 – Wednesday, April 13, where AccuVein will be demonstrating its latest vein visualization device, the AV500, and showcasing its robust education/training program.
“We are acutely aware that the COVID-19 pandemic has placed an additional burden on the nursing profession by exposing nurses to conditions that threaten their health, well-being, and overall ability to provide clinical care, said Thomas Hopkins, Chief Medical Officer at AccuVein Inc. “We are extremely proud and committed to offering our healthcare heroes the latest advancement in NIR vein visualization technology, which can help limit their exposure to infectious diseases, while improving PIV efficiency and recovering valuable nursing time. Additionally, we now provide customized training and education support to address and alleviate nursing stress and anxiety, and help with onboarding new staff,” added Hopkins.
Recent studies demonstrate that AccuVein guided PIV assessment and insertion can reduce procedure time by 78%* and increase the nurse’s ability to achieve peripheral intravenous catheter (PIVC) first stick success by 92%*, resulting in improved PIV efficiency and effectiveness. In addition, AccuVein can also reduce the risk of cross contamination to other staff members by decreasing the need for escalation calls by 45%* to the IV team or to a more costly ultrasound guided IV insertion procedure. These study results suggest that AccuVein helps nurses limit their exposure to COVID-19. To view additional clinical evidence supporting the utility of AccuVein, click here.
Up to 90% of patients receive IV therapy at some point during their hospital stay, making it the most commonly performed invasive medical procedure. Although it is routine, venipuncture can be technically challenging. When multiple venous access attempts are required, it is associated with increased patient morbidity, as well as increased utilization of staff and medical supplies.
Additionally, the Infusion Nursing Society’s (INS) 2021 Infusion Therapy Standards clearly link NIR vein visualization to improvement in outcomes and the overall patient experience, further underscoring its application in a clinical setting. As the Standards state, “It is important that vascular visualization technology is employed to increase insertion success of the most appropriate, least invasive vascular access device (VAD), minimizing the need to escalate to an unnecessary, more invasive device and to reduce insertion-related complications.”
About AccuVein Inc.
AccuVein Inc. is a pioneer in the development of novel medical technologies that enable health professionals to improve vein assessment and preserve vascular health. The company has developed the only patented, eye-safe, laser-based device, the AV500, which uses near-infrared (NIR) technology to help clinicians see superficial veins, valves, and bifurcations for better- informed decision making and accurate needle/catheter placement. AccuVein is in use at more than 5,000 facilities and available for sale in over 130 countries worldwide. To see a demonstration of AccuVein AV500 in action and to learn more, please visit here.
*Data on file
Contacts
Media:
Jason Ford – JDF Communications
908-868-4554
[email protected]
